You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
石四藥集團(02005.HK)首季營業額達12.31億港元 同比增長29.5%
格隆匯 04-30 12:10

格隆匯4月30日丨石四藥集團(02005.HK)公佈集團截至2021年3月31日止3個月的未經審核經營業績。

集團的大部份銷售於中國進行。按港元計,集團截至2021年3月31日止3個月的未經審核營業額較2020年同期增加29.5%至約12.31億港元(2020年同期:約9.51億港元)。集團截至2021年3月31日止3個月的未經審核毛利約為7.87億港元(2020年同期:約5.62億港元),較2020年同期增加40.1%。集團截至2021年3月31日止3個月的未經審核毛利率約為64.0%,較2020年同期增加4.9個百分點。

截至2021年3月31日止3個月,集團的未經審核公司股東應占溢利較2020年同期減少10.6%至約1.94億港元(2020年同期:約2.16億港元),主要原因是於2021年1月12日公司向集團若干管理層員工授出1億份購股權。截至2021年3月31日止3個月因該購股權產生一次性非現金費用約0.67億港元,而2020年同期則並無授出購股權。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account